Sanofi India — 360° view

Sanofi India, a company in the Pharmaceuticals industry, reported revenue of ₹492 crore and net profit of ₹117 crore for the September 2026 quarter.

Sanofi India (NSE: SANOFI) closed at ₹3,206.10 on 20 Nov 2026, down 29.8% over the past year. Its market capitalisation is ₹7,384 crore and it trades at 20.3 times earnings.

Share price
₹3,206.10 (20 Nov 2026)
Market cap
₹7,384 Cr (20 Nov 2026)
P/E
20.26 (20 Nov 2026)
Revenue
₹492 Cr (September 2026 quarter)
Net profit
₹117 Cr (September 2026 quarter)
ROCE
57.5% (FY25)
ROE
43.0% (FY25)
Book value
₹359 (FY25)
Dividend yield
3.84% (last 12 months to 20 Nov 2026)
52-week high / low
₹4,588.70 / ₹2,758.20 (20 Nov 2026)
1-year return
-29.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SANOFI

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.